Deloitte’s Health Informatics
A solution to bring real world healthcare insights to help transform health outcomes
Deloitte and Intermountain Healthcare have established a collaboration that brings together Deloitte’s leading-class professional services and informatics capabilities with Intermountain’s access to patients and pioneering experiences in data-driven care. This collaboration will provide market-leading health analytics solutions that will enable providers and manufacturers to unlock the power of big data, improve quality and drive efficiencies in the delivery of care and the development of new therapies. Deloitte and Intermountain will engage other leading healthcare systems to create a community of healthcare researchers working together to accelerate the development of what the Institute of Medicine refers to as a ‘learning health care system.1
By harnessing the power of rich, patient level clinical data and integrated studies performed by our provider community on patients, we will provide life science product developers, manufacturers and researchers with a transformative service that generates real world evidence designed to help achieve critical decision making in a fraction of the time of conventional solutions.
|Health care data-as-a-service
Health systems are seeking to prepare their data management environments for the era of big data. Learn more.
|Comparative effectiveness research in the United States: Update and implications
This Issue Brief revisits CER following the enactment of health care reform legislation and shares implications for stakeholders.
|Honest broker datasheet
This plays a significant role in providing a spectrum of research activities that are based on patient data
|Value-based pricing for pharmaceuticals
This issue brief summarizes what is known to date about value-based pricing and identifies opportunities for additional exploration.
|2012 Deloitte-AMIA health informatics industry maturity survey
This report explores how health informatics was valued in the industry and how confident organizations were in their ability to realize that value. Read more.
Deloitte offers three products to address these pressing issues in health care:
PopulationMiner: The Real World Evidence analytics tool that provides descriptive views of entire populations in the context of outcomes of interest, helping life sciences manufacturers develop greater insight into relationships between drugs, disease and treatments and physiological states of patient cohorts spanning multiple therapy areas and across more than a decade. Learn more
OutcomesMiner: Deloitte’s high-end analytic tool allows users to “mine” leading health system data and helps them understand the impact of clinical treatments and their associated outcomes. OutcomesMiner gives users a population view of associated outcomes and allows users to filter for sub-populations using particular phenotypic characteristics and specific medical associations. Through an innovative, double-blinded data format, customers are able to access insights derived from real and granular patient healthcare data without the risk of exposure to Personal Health Information (PHI).
Retrospective Analysis: Leveraging the findings from OutcomesMiner, Deloitte connects customers to some of the world’s leading researchers at its community of healthcare providers to undertake patient-level analyses to better understand the causality of clinical process level outcomes.
Prospective Studies: OutcomesMiner users are able to conduct observational or interventional prospective research that taps into the same patients who initially drove the insights generated by the Mining tool. This prospective research can incorporate custom data of interest into customized longitudinal studies.
To request a product demo, please contact: firstname.lastname@example.org
Bottom line benefits
- Support comparative effectiveness research, new product planning activities, HEOR objectives and provide observational insights that can support pharmacovigilance objectives and commercial decision making.
- Eliminate the risk of exposure to Personal Health Information.
- Reduce data distortion by conducting analyses behind provider firewalls, before data has been stripped of valuable identifiers, using Deloitte’s proprietary tools.
- Engage directly with collaborating healthcare providers to conduct retrospective and prospective studies to better understand and confirm causality of specific outcomes with the patients who drove the initial insights.
- Generate rapid insights at a fraction of the cost researchers often pay to purchase and manage large datasets, whose data is frequently less granular than Deloitte’s collaborators' data.
Deloitte's Health Informatics team
Managing Director, Deloitte Health Informatics LLC & Principal, Deloitte Consulting LLP
|Brett J. Davis
Principal, Deloitte Consulting LLP and General Manager, Deloitte Health Informatics LLC
Chief Technology Officer, Deloitte Health Informatics LLC & Director, Deloitte Consulting LLP
Vice President Product Management, Deloitte Health Informatics LLC
Enterprise Data Architect, Deloitte Health Informatics LLC & Specialist Leader, Deloitte Consulting LLP
Business Development Manager, Deloitte Health Informatics LLC & Manager, Deloitte Consulting LLP
Product Development Manager, Deloitte Health Informatics LLC & Manager, Deloitte Consulting LLP
Deloitte's Health Informatics internal advisory
Chief Operating Officer, Deloitte Investments LLC
Vice Chairman, U.S. Life Sciences & Health Care Leader, U.S. Health Plans Leader, Deloitte LLP
National Managing Director for Life Sciences and Health Care, Deloitte Consulting LLP
Managing Principle for Innovation, Deloitte LLP & Principal, Deloitte Consulting LLP
Chairman and CEO, Deloitte Consulting LLP
National Managing Director, Operations and Finance, Deloitte Consulting LLP
Principal, Deloitte Consulting LLP & National Service Line Leader for Information Management, Deloitte Consulting LLP
National Managing Partner - Corporate Development, Deloitte LLP
Principal, Deloitte Consulting LLP & Public Sector National Industry Leader, Deloitte Consulting LLP
National Managing Director of Innovation, Deloitte Consulting LLP
Vice Chairman and Managing Partner, U.S. Merger & Acquisition Services, Deloitte LLP
1 Best Care at Lower Cost: The Path to Continuously Learning Health Care in America
As used in this document, "Deloitte" means Deloitte Health Informatics LLC, a subsidiary of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.